2B Blackbio Obtains CE Marking for Identifying Fungal Infections

2B Blackbio, dedicated to developing and marketing new solutions for personalized medicine, has obtained CE Marking for BlackLight Fungal ID Kit, intended for a fast and easy‐to‐use diagnostic test, allowing rapid identification of fungal infections. BlackLight Fungal ID Kit allows the detection and...

Burrill Builds Digital Health Team

Burrill & Company recently announced that Dr. Dirk Lammerts has been appointed as Managing Director of Digital Health. This follows on the successful Digital Health conference that was held last month in San Francisco. Dr. Lammerts has more than 20 years of professional experience in the healthcare, life...

[Video Profile] TearLab Corporation

Patients who dread traditional blood tests (and the accompanying needles) may one day have reason to rejoice. San Diego device company TearLab is developing a point-of-care diagnostic test that uses tears to identify disease-indicating protein biomarkers. Tears contain many of the same proteins as blood, but...

[Video Profile] Inovio Biomedical Corporation

Solid tumors represent 85 percent of all cancers, creating a huge clinical need for localized, site-specific cancer treatment. Inovio Medical Corporation of San Diego is developing DNA-based vaccines that harness the body’s immune system to prevent and treat chronic diseases such as cancer and HIV. Their...

New Test May Predict Risk of Breast Cancer Metastasis

Researchers at New York-Presbyterian Hospital and Weill Cornell Medical Center have created a test that could help doctors identify which breast cancer patients need aggressive therapy. The study, published in the online version of Clinical Cancer Research, could prevent many women from undergoing...

Recommended Reading: Navigating the Sea Change

After 40-plus years since the biotechnology industry began, it finally turned a profit in 2008. Yet this “good news” story has been overshadowed by the events that besieged the industry in the final four months of the year. With life sciences leaders struggling to make sense of this turbulent period,...